1. Home
  2. NUVB vs WB Comparison

NUVB vs WB Comparison

Compare NUVB & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.98

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Weibo Corporation

WB

Weibo Corporation

HOLD

Current Price

$10.20

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVB
WB
Founded
2018
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NUVB
WB
Price
$8.98
$10.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$10.63
$14.00
AVG Volume (30 Days)
6.1M
873.3K
Earning Date
11-03-2025
11-18-2025
Dividend Yield
N/A
16.16%
EPS Growth
N/A
20.16
EPS
N/A
1.76
Revenue
$26,748,000.00
$1,740,785,000.00
Revenue This Year
$609.55
$0.53
Revenue Next Year
$197.91
$2.38
P/E Ratio
N/A
$5.78
Revenue Growth
1137.19
N/A
52 Week Low
$1.54
$7.10
52 Week High
$9.75
$12.96

Technical Indicators

Market Signals
Indicator
NUVB
WB
Relative Strength Index (RSI) 61.71 49.09
Support Level $8.84 $10.00
Resistance Level $9.75 $10.29
Average True Range (ATR) 0.43 0.17
MACD -0.11 0.03
Stochastic Oscillator 56.50 56.82

Price Performance

Historical Comparison
NUVB
WB

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

Share on Social Networks: